News

August 9, 2018August 9, 2018

IBD Increases Risk of Shingles, More Vaccinations Needed, Study Says

News

People with inflammatory bowel disease (IBD) appear to have an increased risk of herpes zoster infection (shingles), and Canadian researchers warn that low vaccination rates have been insufficient to reduce ... Read more

August 8, 2018August 8, 2018

Complete Start Wins First-ever Lyfebulb and UnitedHealth Group Innovation Award

News

The CEO of Complete Start, a company selling nutritious breakfast shakes for inflammatory bowel disease (IBD) patients, won the first-ever Lyfebulb and UnitedHealth Group Innovation Award “Empowering Patients: An Innovation Challenge ... Read more

August 6, 2018August 6, 2018

CHMP Favors Approval of Hulio, Biosimilar to Humira, to Treat IBD Patients in EU

News

Hulio, a biosimilar to Humira (adalimumab), has been given a favorable opinion by the Committee for Medicinal Products for Human Use (CHMP) to treat a number of inflammatory diseases in the EU — including ... Read more

August 3, 2018August 3, 2018

Pfizer’s Xeljanz Approved in EU for Adults with Moderate to Severe Ulcerative Colitis

News, Ulcerative colitis

The European Commission has approved Pfizer‘s Xeljanz (tofacitinib) for the treatment of adults with moderate to severe active ulcerative colitis (UC) who have failed to fully respond to other therapies. The ... Read more

August 1, 2018August 1, 2018

RHB-104 Shows Promise for Crohn’s Disease Remission in Phase 3 Trial

News

RedHill Biopharma’s experimental therapy RHB-104 significantly increases the remission and response rates of patients with Crohn’s disease, according to top-line Phase 3 trial results recently announced by the company. The ... Read more

July 30, 2018July 30, 2018

Qu Biologics Recruiting Crohn’s Patients in Canada for Phase 2 Trial, Hosting Webinar

News

Qu Biologics has started enrolling patients in the RESTORE Phase 2 trial to evaluate its lead investigative immunotherapy, QBECO SSI, in patients with moderate to severe Crohn’s disease. The study ... Read more

July 26, 2018July 26, 2018

Viruses That Infect Gut Bacteria May Play Role in IBD, Mouse Study Suggests

News

Populations of bacteria-infecting viruses, called bacteriophages, were found to be altered in the intestines of a mouse model of colitis, indicating that these viruses may be involved in inflammatory bowel ... Read more

July 25, 2018July 25, 2018

Vegetables, Whole Grains, Fruit, Beans Lower Risk of IBD, Study Suggests

News

Eating vegetables and whole grains reduces the risk of Crohn’s disease, while eating more fruit and beans/legumes lowers the risk of ulcerative colitis (UC), according to researchers in Canada. In turn, ... Read more

July 23, 2018July 23, 2018

Nextbiotix Receives €7 Million for Development of Bacteria-based IBD Therapy

News

Nextbiotix has secured €7 million ($8.2 million) in funding to develop NBX1650, the company’s lead bacterial candidate for the treatment of inflammatory bowel disease (IBD). This first round of funding ... Read more

July 20, 2018July 20, 2018

Mental Health of Priority in Treating IBD Patients Due to Possibly Higher Suicide Risk, Study Says

News

People with inflammatory bowel disease (IBD) may be at a higher risk of suicide than those without this disorder, according to a study by researchers in Canada. Their findings indicate ... Read more